Published in Endocrinology on December 01, 1991
Vitamin D metabolism and action in human bone marrow stromal cells. Endocrinology (2009) 1.16
Vitamin D and bone. Curr Osteoporos Rep (2012) 1.08
Cellular actions of insulin-like growth factor binding proteins. Horm Metab Res (1999) 1.00
Vitamin D and gene networks in human osteoblasts. Front Physiol (2014) 0.89
Research resource: whole transcriptome RNA sequencing detects multiple 1α,25-dihydroxyvitamin D(3)-sensitive metabolic pathways in developing zebrafish. Mol Endocrinol (2012) 0.86
Hypocalcitonemia in Handigodu Disease: a spondylo epi (meta) physeal dysplasia. Int J Clin Exp Med (2010) 0.78
Skeletal effects of growth hormone and insulin-like growth factor-I therapy. Mol Cell Endocrinol (2015) 0.76
Normal and osteoporotic human osteoblast behaviour after 1,25-dihydroxy-vitamin D(3) stimulation. Rheumatol Int (2008) 0.76
Generation and characterization of two immortalized human osteoblastic cell lines useful for epigenetic studies. J Bone Miner Metab (2016) 0.75
Genetic variability in adult bone density among inbred strains of mice. Bone (1996) 3.66
Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J Cell Biol (1987) 3.28
Synthesis, Fourier transform infrared and Raman spectra, assignments and analysis of N-(phenyl)- and N-(chloro substituted phenyl)-2,2-dichloroacetamides. Spectrochim Acta A Mol Biomol Spectrosc (2004) 3.04
Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice. J Bone Miner Res (2001) 2.94
Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev (1997) 2.63
Myogenic differentiation in permanent clonal mouse myoblast cell lines: regulation by macromolecular growth factors in the culture medium. Dev Biol (1981) 2.20
Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. J Clin Endocrinol Metab (1998) 2.17
Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. Bone (1997) 2.09
IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol (2002) 2.01
Incorporation of sodium fluoride into cortical bone does not impair the mechanical properties of the appendicular skeleton in rats. Calcif Tissue Int (1992) 1.95
Cloning and analysis of ermG, a new macrolide-lincosamide-streptogramin B resistance element from Bacillus sphaericus. J Bacteriol (1987) 1.94
The amino acid sequence of the alpha-chain of human fibrinogen. Nature (1979) 1.92
Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc Natl Acad Sci U S A (2000) 1.90
Control of mouse myoblast commitment to terminal differentiation by mitogens. J Supramol Struct (1980) 1.89
A simple method for enriching populations of transfected CHO cells for cells of higher specific productivity. J Immunol Methods (2003) 1.87
Glucocorticoid-induced osteoporosis. N Engl J Med (1983) 1.74
UDP-N-acetylglucosamine acyltransferase of Escherichia coli. The first step of endotoxin biosynthesis is thermodynamically unfavorable. J Biol Chem (1993) 1.72
Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women. J Clin Endocrinol Metab (2001) 1.70
Quantitative trait loci for bone density in C57BL/6J and CAST/EiJ inbred mice. Mamm Genome (1999) 1.68
Nucleotide sequence, organisation and structural analysis of the products of genes in the nirB-cysG region of the Escherichia coli K-12 chromosome. Eur J Biochem (1990) 1.66
Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. Endocrinology (1998) 1.66
Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab (1994) 1.63
TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage. J Cell Biochem (1999) 1.62
Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass. Metabolism (1977) 1.61
Regulation of serum 1alpha,25-dihydroxyvitamin D3 by calcium and phosphate in the rat. Science (1975) 1.60
Growth factors for bone growth and repair: IGF, TGF beta and BMP. Bone (1996) 1.53
Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy. Kidney Int (2000) 1.52
Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects. Osteoporos Int (1995) 1.51
Quantification of skeletal alkaline phosphatase in osteoporotic serum by wheat germ agglutinin precipitation, heat inactivation, and a two-site immunoradiometric assay. Clin Chem (1994) 1.50
Phosphotyrosyl protein phosphatases. Biochem J (1989) 1.49
INFORMAS (International Network for Food and Obesity/non-communicable diseases Research, Monitoring and Action Support): overview and key principles. Obes Rev (2013) 1.46
Identification of a region of human fibrinogen interacting with staphylococcal clumping factor. Biochemistry (1982) 1.45
Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum (1993) 1.42
The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Cancer Res (1999) 1.42
Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism (1984) 1.41
FTIR and FTRaman spectra, assignments, ab initio HF and DFT analysis of 4-nitrotoluene. Spectrochim Acta A Mol Biomol Spectrosc (2010) 1.41
Nuclear entry of nonviral vectors. Gene Ther (2005) 1.40
Prevention and treatment of glucocorticoid-induced osteoporosis. A pathogenetic perspective. Chest (1992) 1.40
Bone growth factors. Clin Orthop Relat Res (1991) 1.39
Attenuation of posttraumatic muscle catabolism and osteopenia by long-term growth hormone therapy. Ann Surg (2001) 1.38
Antibodies against synthetic peptides reveal that the unidentified reading frame A6L, overlapping the ATPase 6 gene, is expressed in human mitochondria. Cell (1983) 1.37
Exercise and mechanical loading increase periosteal bone formation and whole bone strength in C57BL/6J mice but not in C3H/Hej mice. Calcif Tissue Int (2000) 1.36
Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene. Eur J Hum Genet (1999) 1.36
Identification of transcription activators that regulate gonococcal adaptation from aerobic to anaerobic or oxygen-limited growth. Mol Microbiol (2000) 1.36
Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab (2005) 1.35
Identification of wound healing/regeneration quantitative trait loci (QTL) at multiple time points that explain seventy percent of variance in (MRL/MpJ and SJL/J) mice F2 population. Genome Res (2001) 1.35
Genetic regulation of cortical and trabecular bone strength and microstructure in inbred strains of mice. J Bone Miner Res (2000) 1.35
Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab (1996) 1.34
Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol. J Clin Invest (1975) 1.33
Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. J Biol Chem (1981) 1.33
Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone-forming cells. Science (1983) 1.32
Evidence that IGF-binding protein-5 functions as a growth factor. J Clin Invest (2001) 1.32
Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action. Metabolism (1983) 1.32
Estrogen receptor specificity in the regulation of the skeleton in female mice. J Endocrinol (2001) 1.31
Postnatal and pubertal skeletal changes contribute predominantly to the differences in peak bone density between C3H/HeJ and C57BL/6J mice. J Bone Miner Res (2001) 1.31
Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab (1989) 1.31
gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors. Proc Natl Acad Sci U S A (1982) 1.30
Isolation, characterization, and synthesis of peptides from human fibrinogen that block the staphylococcal clumping reaction and construction of a synthetic clumping particle. Biochemistry (1982) 1.28
Evidence that anabolic effects of PTH on bone require IGF-I in growing mice. Endocrinology (2001) 1.28
Chyluria presenting as milky urine and nephrotic-range proteinuria. Kidney Int (2006) 1.27
Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients. J Endocrinol (1998) 1.27
Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. Endocrinology (1999) 1.27
Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism. Proc Natl Acad Sci U S A (1981) 1.25
Impact of ultrasonography on central venous catheter insertion in intensive care. Indian J Radiol Imaging (2009) 1.24
The insulin-like growth factor system and the coupling of formation to resorption. Bone (1995) 1.24
Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab (1999) 1.24
Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem (1995) 1.23
The assay of 1alpha,25-dihydroxyvitamin D3: physiologic and pathologic modulation of circulating hormone levels. Clin Endocrinol (Oxf) (1976) 1.23
Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3. J Clin Invest (1976) 1.22
Comparison of the biological actions of TGF beta-1 and TGF beta-2: differential activity in endothelial cells. J Cell Physiol (1988) 1.22
Monitoring the price and affordability of foods and diets globally. Obes Rev (2013) 1.22
2-[(E)-(4-Chlorophenyl)methyleneamino]-N-(X-methylphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide, where X = 2 and 3. Acta Crystallogr C (2004) 1.21
Development of an MFG-based retroviral vector system for secretion of high levels of functionally active human BMP4. Mol Ther (2001) 1.20
Inhibition of bone formation during space flight. Science (1978) 1.19
Monitoring the impacts of trade agreements on food environments. Obes Rev (2013) 1.18
Bone formation by osteocytes. Am J Physiol (1971) 1.17
Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. Endocrinology (1999) 1.16
Quantitative trait loci for bone density in mice: the genes determining total skeletal density and femur density show little overlap in F2 mice. Calcif Tissue Int (2002) 1.16
Lamprey fibrinogen gamma chain: cloning, cDNA sequencing, and general characterization. Biochemistry (1985) 1.16
Molecular mechanism of action of fluoride on bone cells. J Bone Miner Res (1998) 1.16
Kidneys at higher risk of discard: expanding the role of dual kidney transplantation. Am J Transplant (2014) 1.15